Clinical Trials on Coronary Heart Disease Risk

Total 66879 results

Air Liquide Santé International
Eurofins Biomnis; MONITORING FORCE GROUP CROs; Inferential

Completed

Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery (CARVASAXe)

Elevated Cardiac Risk | Coronary Arteries Disease Risk

France
Boston Scientific Corporation

Not yet recruiting

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) (VITALYST EFS)

Heart Disease, Coronary | High-risk Percutaneous Coronary Intervention

United States, Sweden
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Validation and Field Test for Risk Appraisal Instruments

Heart Diseases | Cardiovascular Diseases | Coronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Fat Reduction Intervention Trial in African-Americans

Heart Diseases | Cardiovascular Diseases | Coronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Self-Scored Cardiovascular Disease Risk Appraisal

Heart Diseases | Cardiovascular Diseases | Coronary Heart Disease Risk Reduction
Duke University

Completed

GENErating Behavior Change, An Integrative Health Coaching and Genetic Risk Testing Pilot

Coronary Heart Disease Risk
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation of Low Literacy CVD Nutrition Education

Heart Diseases | Cardiovascular Diseases | Coronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Trial of Smoking Cessation Programs in Black Churches

Heart Diseases | Cardiovascular Diseases | Coronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Children's Activity and Nutrition (SCAN)--Extended Analyses

Heart Diseases | Cardiovascular Diseases | Coronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Community Site Coronary Risk Control in Black Families

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Coronary Heart Disease Risk Reduction
Merck Sharp & Dohme LLC

Completed

Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019) (DEFINE)

Coronary Heart Disease (CHD) | CHD Risk-Equivalent Disease
University Medicine Greifswald
German Center of Cardiovascular Diseases (DZHK)

Completed

Adherence to an Exercise and Healthy Diet Program in Patients With Coronary Heart Disease Aged ≥ 60 Years (RE-Start60+)

Coronary Heart Disease | Risk Reduction Behavior | Adherence, Treatment

Germany
Boston Children's Hospital

Completed

FITT Exercise Counseling With Interactive Accelerometry and Physical Activity in Adolescents at Increased Risk of Early Cardiovascular Disease: A Pilot Study

Coronary Artery Disease Risk High

United States
Seoul National University Hospital
Samsung Medical Center; Seoul St. Mary's Hospital; Asan Medical Center; Seoul National... and other collaborators

Unknown

Comparison of the Cost-Effectiveness of Coronary CT Angiography Versus Myocardial SPECT in Patients With Intermediate Risk of Coronary Heart Disease (CARE-CCTA)

Chest Pain | Coronary Heart Disease Risk

Korea, Republic of
Aristotle University Of Thessaloniki
LABNET IAE - Private Reference Diagnostic Laboratory

Unknown

Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease

Coronary Artery Disease | Coronary Arteriosclerosis | Cardiovascular Risk Factor

Greece
University Hospital, Basel, Switzerland

Recruiting

Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors

Physical Activity | Coronary Heart Disease | Cardiovascular Risk Factors

Switzerland
AstraZeneca

Completed

A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

High Risk Coronary Artery Disease

United Kingdom
Cui Yimin

Unknown

Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention

Coronary Heart Disease | Percutaneous Coronary Intervention | Restenosis | Clopidogrel | Smoking Status | Genetic Risk Factors

China
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation of Cholesterol Education for At-Risk Children

Heart Diseases | Cardiovascular Diseases | Hypercholesterolemia | Coronary Heart Disease Risk Reduction
University Hospital Plymouth NHS Trust

Completed

Cardiac GSI Feasibility Study

High Risk of Significant Coronary Artery Disease

United Kingdom
Tufts Medical Center
National Heart, Lung, and Blood Institute (NHLBI); Sinai Hospital of Baltimore

Completed

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

Vascular Disease | Coronary Artery Disease Risk Factors Multiple

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Population-Based Modeling of Cholesterol Lowering in the United States

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypercholesterolemia | Coronary Heart Disease Risk Reduction
Abbott Medical Devices

Completed

HeartMate PHP™ CE Mark Clinical Investigation Plan (HM PHP CE Mark)

High Risk Percutaneous Coronary Intervention

Colombia, Netherlands, Paraguay, Poland
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Providers for Smoking Prevention Programs

Heart Diseases | Cardiovascular Diseases | Lung Diseases | Coronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Primary Prevention of CHD Risk Factors Occurring in US

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypertension | Hypercholesterolemia | Coronary Heart Disease Risk Reduction
National Institute of Cardiology, Warsaw, Poland

Enrolling by invitation

Dietary Intervention to Stop Coronary Atherosclerosis in Computed Tomography: Long-Term Follow-Up (DISCO-CT2)

Coronary Artery Disease | Diet, Healthy | Lifestyle Risk Reduction

Poland
Loughborough University
Teesside University

Completed

Individual Variability of Coronary Heart Disease Risk Markers and Sleep Responses to Exercise

Sleep | Blood Pressure | Coronary Heart Disease | Cardiovascular Risk Factor | Arterial Stiffness

United Kingdom
Universidade Federal de Sao Carlos

Unknown

Optimization of Interval Exercise Based-intensity on Ventilatory Anaerobic Threshold in Coronary Artery Disease

Coronary Artery Disease | Cardiovascular Risk Factors

Brazil
Magenta Medical Ltd.

Recruiting

Magenta Elevate™ EFS in High-Risk PCI Patients

High-risk Percutaneous Coronary Intervention

United States
Abiomed Inc.

Active, not recruiting

Impella ECP Early Feasibility Study (ECP EFS)

High-risk Percutaneous Coronary Intervention

United States
Magenta Medical Ltd.

Active, not recruiting

Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients (ELEVATE I)

High-Risk Percutaneous Coronary Intervention

Georgia
Augusta University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Children's Activity and Nutrition (SCAN)

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypertension | Obesity | Hypercholesterolemia | Coronary Heart Disease Risk Reduction
CardioVascular Research Foundation, Korea

Completed

Asan Medical Center CCTA Registry

Coronary Artery Disease | Computed Tomography | Risk Factor
Biotronik France
MedPass International

Unknown

PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon (PaneLux PTCA)

Coronary Artery Disease | High Bleeding Risk Patients

France
Abiomed Inc.

Enrolling by invitation

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

High-Risk Percutaneous Coronary Intervention

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Atherosclerosis Risk in Communities (ARIC)

Heart Diseases | Cardiovascular Diseases | Heart Failure | Coronary Disease | Diabetes Mellitus | Atherosclerosis | Heart Failure, Congestive | Coronary Heart Disease Risk Reduction
Xijing Hospital

Recruiting

Interventional Ventricular Assist System for PCI in CHIP Patients (REC-CHIPMCS)

High-Risk Percutaneous Coronary Intervention (High-risk PCI) | Left Ventricular Assist Devices

China
Stanford University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Improving Coronary Prevention in a County Health System

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Risk Reduction
Biosensors Europe SA

Recruiting

ULTRA LONG: BioFreedom Ultra

Coronary Artery Disease | High Bleeding Risk Patients

United Kingdom
Instituto Nacional de Cardiologia Ignacio Chavez

Recruiting

Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk (ZEVS-HBR)

Coronary Artery Disease | Percutaneous Coronary Intervention | High Bleeding Risk

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez

Terminated

Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty (DEBORA)

Coronary Artery Disease (CAD) | Percutaneous Coronary Intervention (PCI) | High Bleeding Risk

Mexico
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Prospective Study of Health in Runners and Walkers

Heart Diseases | Cardiovascular Diseases | Neoplasms | Coronary Disease | Breast Neoplasms | Coronary Heart Disease Risk Reduction
Federal State Budgetary Institution National Medical...
Kemerovo Cardiology Center, Tarasov Roman Sergeevich; Tomsk National Research...

Recruiting

Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coronary Artery Disease (NSTE-ACSMT)

Coronary Syndrome, Acute, Non-ST Elevation, High Risk Patients

Russian Federation
Lady Davis Institute

Completed

Cardiovascular Screening for Family Members of People With Acute Coronary Disease

Cardiovascular Risk Factor

Canada
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Laboratory Implications of Non Obstructive Atherosclerotic Plaques Identified by Multiple Detector Coronary Angiotomography

Cardiovascular Risk Factor | Platelet Aggregation, Spontaneous | Discrete Coronary Artery Stenosis | Coronary Angiography of Multiple Detectors

Brazil
University of Oklahoma
VA Office of Research and Development

Completed

Low Risk Acute Coronary Syndrome (LOW ACT)

Low Risk Acute Coronary Syndrome

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Thrombosis | Hyperlipoproteinemia | Coronary Heart Disease Risk Reduction
Cairo University

Completed

Watch Laser Acupuncture With Nasal Radiation for Prevention of Coronary Artery Disease

Coronary Artery Disease | Cardiovascular Risk Factor

Egypt
Pi-cardia

Completed

The ShortCut™ Study Protocol

Risk of Coronary Obstruction Following TAVR Procedure

United States, Germany, Israel, United Kingdom, France
Beijing Anzhen Hospital

Unknown

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD) (FORWARD)

Dyslipidemia | High Risk Coronary Artery Disease

China

Clinical Trials on Coronary Heart Disease Risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations